An Observational, Safety and Efficacy Study in Subjects Using Levemir (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 14 Oct 2014
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms DIABESITY
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 16 Oct 2009 Actual patient number changed from 9764 to 9868 as reported by ClinicalTrials.gov.
- 16 Mar 2009 Actual patient number (9764) added as reported by ClinicalTrials.gov.